ABBV stock has seen strong gains of 85% from levels of $90 in early January 2021 to around $165 now, vs. an increase of about ...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson & Johnson (NYSE:JNJ) is about to trade ex-dividend in the next 3 days. The ex-dividend ...

Notably, the $205 average of analysts’ price estimate for ABBV, reflects over 20% upside from its current levels of around $165. While ABBV stock may outperform JNJ stock in the next three years ...

Current price $152.88 52-week high $168.85 ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Johnson & Johnson faces uncertainty with speculation about RFK Jr. at HHS. Learn why JNJ stock remains a buy despite ...

J&J JNJ stock has plunged 6.1% in a month, losing almost $24 billion of its market value. Though slowing sales in its MedTech ...

JOHNSON & JOHNSON (JNJ) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 81% based on the firm’s underlying fundamentals and the stock’s ...